Search Results

There are 2212953 results for: content related to: Topical therapy for oropharyngeal symptoms of myasthenia gravis

  1. You have free access to this content
    Pyridostigmine but not 3,4-diaminopyridine exacerbates ACh receptor loss and myasthenia induced in mice by muscle-specific kinase autoantibody

    The Journal of Physiology

    Volume 591, Issue 10, May 2013, Pages: 2747–2762, Marco Morsch, Stephen W. Reddel, Nazanin Ghazanfari, Klaus V. Toyka and William D. Phillips

    Version of Record online : 25 MAR 2013, DOI: 10.1113/jphysiol.2013.251827

  2. Effects of subacute pyridostigmine administration on mammalian skeletal muscle function

    Journal of Applied Toxicology

    Volume 12, Issue 1, February 1992, Pages: 25–33, Michael Adler, Sharad S. Deshpande, Robert E. Foster, Donald M. Maxwell and Edson X. Albuquerque

    Version of Record online : 11 JAN 2006, DOI: 10.1002/jat.2550120107

  3. Cholinergic stimulation with pyridostigmine improves autonomic function in infarcted rats

    Clinical and Experimental Pharmacology and Physiology

    Volume 40, Issue 9, September 2013, Pages: 610–616, Raquel N de La Fuente, Bruno Rodrigues, Ivana C Moraes-Silva, Leandro E Souza, Raquel Sirvente, Cristiano Mostarda, Kátia De Angelis, Pedro P Soares, Silvia Lacchini, Fernanda Consolim-Colombo and Maria-Cláudia Irigoyen

    Version of Record online : 23 AUG 2013, DOI: 10.1111/1440-1681.12121

  4. Plasma pyridostigmine levels in patients with myasthenia gravis

    Clinical Pharmacology & Therapeutics

    Volume 21, Issue 2, February 1977, Pages: 187–193, T. N. Calvey and K. Chan

    Version of Record online : 4 JAN 2016, DOI: 10.1002/cpt1977212187

  5. Pyridostigmine enhances atrial tachyarrhythmias in aging spontaneously hypertensive rats

    Clinical and Experimental Pharmacology and Physiology

    Volume 42, Issue 10, October 2015, Pages: 1084–1091, Halil Sayin, Alina Scridon, Valérie Oréa, Bruno Chapuis, Philippe Chevalier, Christian Barrès and Claude Julien

    Version of Record online : 15 SEP 2015, DOI: 10.1111/1440-1681.12458

  6. Pyridostigmine in the Treatment of Postural Orthostatic Tachycardia: A Single-Center Experience

    Pacing and Clinical Electrophysiology

    Volume 34, Issue 6, June 2011, Pages: 750–755, KHALIL KANJWAL, BEVERLY KARABIN, MUJEEB SHEIKH, LAWRENCE ELMER, YOUSUF KANJWAL, BILAL SAEED and BLAIR P. GRUBB

    Version of Record online : 16 MAR 2011, DOI: 10.1111/j.1540-8159.2011.03047.x

  7. Plasma concentration of pyridostigmine and effects in myasthenia gravis

    Clinical Pharmacology & Therapeutics

    Volume 22, Issue 5part1, November 1977, Pages: 596–601, K. Chan and T. N. Calvey

    Version of Record online : 4 JAN 2016, DOI: 10.1002/cpt1977225part1596

  8. Interactive and delayed effects of pyridostigmine and physical stress on biochemical and histological changes in peripheral tissues of mice

    Journal of Applied Toxicology

    Volume 20, Issue 4, July/August 2000, Pages: 327–334, S. M. Somani, K. Husain, T. Asha and R. Helfert

    Version of Record online : 10 AUG 2000, DOI: 10.1002/1099-1263(200007/08)20:4<327::AID-JAT697>3.0.CO;2-J

  9. Pyridostigmine kinetics in healthy subjects and patients with myasthenia gravis

    Clinical Pharmacology & Therapeutics

    Volume 37, Issue 5, May 1985, Pages: 495–501, Ursula Breyer-Pfaff, Ulrich Maier, Anneliese M Brinkmann and Fritz Schumm

    Version of Record online : 13 MAY 1985, DOI: 10.1038/clpt.1985.78

  10. Retrospective population pharmacokinetic/pharmacodynamic analysis of pyridostigmine, a cholinesterase inhibitor, in Chinese males

    Journal of Pharmacy and Pharmacology

    Volume 61, Issue 9, September 2009, Pages: 1187–1196, Kok-Yong Seng, Weng-Keong Loke, Shabbir Moochhala, Bin Zhao and Jon-Deoon Edmund Lee

    Version of Record online : 8 JAN 2010, DOI: 10.1211/jpp.61.09.0008

  11. The efficacy of treatment of patients with severe constipation or recurrent pseudo-obstruction with pyridostigmine

    Colorectal Disease

    Volume 12, Issue 6, June 2010, Pages: 540–548, C. J. O’Dea, S. J. H. Brookes and D. A. Wattchow

    Version of Record online : 27 MAR 2009, DOI: 10.1111/j.1463-1318.2009.01838.x

  12. Pyridostigmine metabolism in man

    Clinical Pharmacology & Therapeutics

    Volume 13, Issue 3, May 1972, Pages: 393–399, Satu M. Somani, John B. Roberts and Andrew Wilson

    Version of Record online : 4 JAN 2016, DOI: 10.1002/cpt1972133393

  13. GH FEEDBACK OCCURS THROUGH MODULATION OF HYPOTHALAMIC SOMATOSTATIN UNDER CHOLINERGIC CONTROL: STUDIES WITH PYRIDOSTIGMINE AND GHRH

    Clinical Endocrinology

    Volume 27, Issue 6, December 1987, Pages: 727–733, R. J. M. ROSS, S. TSAGARAKIS, A. GROSSMAN, L. NHAGAFOONG, R. J. TOUZEL, L. H. REES and G. M. BESSER

    Version of Record online : 17 MAR 2008, DOI: 10.1111/j.1365-2265.1987.tb02957.x

  14. Interaction of pyridostigmine and physical stress on antioxidant defense system in skeletal muscle of mice

    Journal of Applied Toxicology

    Volume 21, Issue 4, July/August 2001, Pages: 341–348, R. Jagannathan, K. Husain and S. M. Somani

    Version of Record online : 26 JUL 2001, DOI: 10.1002/jat.765

  15. Effectiveness of pyridostigmine in reversing neuromuscular blockade produced by soman

    Journal of Pharmacy and Pharmacology

    Volume 30, Issue 1, September 1978, Pages: 419–425, P. DIRNHUBER and D. M. GREEN

    Version of Record online : 12 APR 2011, DOI: 10.1111/j.2042-7158.1978.tb13278.x

  16. You have free access to this content
    A Comparison of the Efficacy of Newly Developed Reversible Inhibitors of Acetylcholinesterase with Commonly Used Pyridostigmine as Pharmacological Pre-Treatment of Soman-Poisoned Mice

    Basic & Clinical Pharmacology & Toxicology

    Volume 110, Issue 4, April 2012, Pages: 322–326, Jiri Kassa, Kamil Musilek, Marketa Koomlova and Jiri Bajgar

    Version of Record online : 17 NOV 2011, DOI: 10.1111/j.1742-7843.2011.00808.x

  17. You have free access to this content
    The Evaluation of Prophylactic Efficacy of Newly Developed Reversible Inhibitors of Acetylcholinesterase in Soman-Poisoned Mice – A Comparison with Commonly Used Pyridostigmine

    Basic & Clinical Pharmacology & Toxicology

    Volume 115, Issue 6, December 2014, Pages: 571–576, Jiri Kassa, Jan Korabecny, Vendula Sepsova and Martina Tumova

    Version of Record online : 6 JUN 2014, DOI: 10.1111/bcpt.12269

  18. Pretreatment for acute exposure to diisopropylfluorophosphate: in vivo efficacy of various acetylcholinesterase inhibitors

    Journal of Applied Toxicology

    Volume 31, Issue 6, August 2011, Pages: 515–523, Dietrich E. Lorke, Mohamed Y. Hasan, Syed M. Nurulain, Mohamed Shafiullah, Kamil Kuča and Georg A. Petroianu

    Version of Record online : 27 OCT 2010, DOI: 10.1002/jat.1589

  19. You have free access to this content
    DETERMINATION OF NEOSTIGMINE AND PYRIDOSTIGMINE IN THE URINE OF PATIENTS WITH MYASTHENIA GRAVIS

    British Journal of Pharmacology and Chemotherapy

    Volume 18, Issue 3, June 1962, Pages: 617–624, P. T. NOWELL, CAROL A. SCOTT and A. WILSON

    Version of Record online : 19 JUL 2012, DOI: 10.1111/j.1476-5381.1962.tb01181.x

  20. Reversal of rocuronium-induced neuromuscular blockade by pyridostigmine in patients with Duchenne muscular dystrophy

    Pediatric Anesthesia

    Volume 18, Issue 3, March 2008, Pages: 251–255, TINO MUENSTER, JUERGEN FORST, PETER GOERLITZ and HUBERT J. SCHMITT

    Version of Record online : 22 JAN 2008, DOI: 10.1111/j.1460-9592.2008.02417.x